Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty

Archives of Internal Medicine

Volumn 162, Issue 3, 2002, Pages 329-336

  Mueller, Christian ^a,b   Buerkle, Gerd ^a   Buettner, Heinz J ^a   Petersen, Jens ^a   Perruchoud, André P ^b   Eriksson, Urs ^b   Marsch, Stephan ^b   Roskamm, Helmut ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GLUCOSE; IOPROMIDE; ISOTONIC SOLUTION; SODIUM CHLORIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; HYDRATION; INFUSION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0037059951     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.3.329     Document Type: Article

References (36)

1. Acquired renal insufficiency in critically ill patients
2. Hospital-acquired renal insufficiency: A prospective study
3. The effect of acute renal failure on mortality: A cohort analysis
4. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
5. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency
6. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography
7. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both
8. Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent
9. A comparison of nonionic, low-osmolarity radiocontrast agents with ionic, high-osmolarity agents during cardiac catheterization
10. Use of non-ionic or low osmolar contrast agents in cardiovascular procedures
11. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
12. Contrast media-associated nephrotoxicity
13. Nephrotoxicity: Focusing on radiocontrast nephropathy
14. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents
15. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency
16. Prevention of nephrotoxicity induced by radiocontrast agents
17. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus
18. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy
19. 1: A new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media?
20. Captopril for prevention of contrast-induced nephropathy in diabetic patients: A randomised study
21. The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents
22. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy
23. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
24. Prophylaxis against contrast-induced nephropathy
25. Prepared: Preparation for angiography in renal dysfunction: A randomized trial of inpatient versus outpatient hydration protocols for cardiac catheterization in mild to moderate renal dysfunction
26. Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy
27. Measurement of renal function in chronic renal disease
28. Prediction of creatinine clearance from serum creatinine concentration based on lean body mass
29. Should creatinine clearance be normalised to body surface or to lean body mass?
30. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty
31. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology
32. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation
33. Pro-coagulant effect of in vitro haemodilution is not inhibited by aspirin
34. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
35. Vascular complications after balloon and new device angioplasty
36. Salt and blood pressure